Skip to main content
Signal8

Alignment Healthcare (NASDAQ: ALHC) Increasingly Scrutinized Over H3815 Cut Points And CMS Bonus Eligibility - HBSS

$ALHCPress releaseOct 14, 2026, 4:50 PM ETRead the release

Hagens Berman announced an investigation into Alignment Healthcare's disclosures about H3815's eligibility for CMS quality bonus payments after the California HMO contract — serving 75% of membership — was downgraded from 4.0 to 3.5 stars for rating year 2027. Alignment shares fell ~59% between July 30 and October 9, 2026, erasing over $2.2 billion in market cap, with steep drops on CEO John Kao's July 'I feel good about our position' remark, his September refusal to comment on Stars positioning, and the October 8 8-K disclosing the downgrade and loss of 2028 quality bonus eligibility.

Key figures

Market cap loss
over $2.2 billion
Cumulative decline
-59% between July 30 and October 9, 2026
Share decline oct9
-13% to $7.55 (52-week low) on Oct 9, 2026
Membership exposure
H3815 serves 75% of health plan membership
Share decline jul30
-20% on July 30, 2026
Share decline sep15
-20% on September 15, 2026
Star rating downgrade
H3815 downgraded from 4.0 to 3.5 stars for 2027 rating year

AI analysis

Red flags4 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.

    ALHC: Alignment Healthcare (NASDAQ: ALHC) Increasingly Scrutinized Over H3815 Cut Points And CMS Bonus Eligibility - HBSS — AI Analysis | Signal8